[1]
Iannazzo, S. 2021. A comparative analysis of international health technology assessments for novel gene silencing therapies: patisiran and inotersen. Global & Regional Health Technology Assessment. 8, 1 (Mar. 2021), 14–21. DOI:https://doi.org/10.33393/grhta.2021.2193.